© 2005 Oxford University Press
BRIEF COMMUNICATION |
OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of Action
Affiliations of authors: Departments of Molecular Pathology (YZ, CG-P, DAC, RX, HP, PH), Leukemia (DAC, DMH, ZE, MJK), Neuro-Surgery (SK), and Pathology (JL), The University of Texas M. D. Anderson Cancer Center, Houston, TX; College of Pharmacy, Division of Medicinal & Natural Products Chemistry, The University of Iowa, Iowa City, IA (YK, WY, CL, ZJ)
Correspondence to: Peng Huang, MD, PhD, Department of Molecular Pathology, Box 089, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030 (e-mail:phuang{at}mdanderson.org).
The naturally occurring compound 3
,16,17
-trihydroxycholest-5-en-22-one 16-O-(2-O-4-methoxybenzoyl--D-xylopyranosyl)-(1
3)-(2-O-acetyl--L-arabinopyranoside) (OSW-1) is found in the bulbs of Ornithogalum saudersiae and is highly cytotoxic against tumor cell lines. Using various human cancer and nonmalignant cell lines, we investigated the anticancer activity and selectivity of OSW-1 and its underlying mechanisms of action. OSW-1 exhibited extremely potent cytotoxic activity against cancer cells in vitro. Nonmalignant cells were statistically significantly less sensitive to OSW-1 than cancer cells, with concentrations that cause a 50% loss of cell viability 40–150-fold greater than those observed in malignant cells. Electron microscopy and biochemical analyses revealed that OSW-1 damaged the mitochondrial membrane and cristae in both human leukemia and pancreatic cancer cells, leading to the loss of transmembrane potential, increase of cytosolic calcium, and activation of calcium-dependent apoptosis. Clones of leukemia cells with mitochondrial DNA defects and respiration deficiency that had adapted the ability to survive in culture without mitochondrial respiration also were resistant to OSW-1. In vitro analysis revealed that OSW-1 effectively killed primary leukemia cells from chronic lymphocytic leukemia patients with disease refractory to fludarabine. The promising anticancer activity of OSW-1 and its unique mechanism of action make this compound worthy of further investigation for its potential to overcome drug resistance.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Rahmani, E. M. Davis, T. R. Crabtree, J. R. Habibi, T. K. Nguyen, P. Dent, and S. Grant The Kinase Inhibitor Sorafenib Induces Cell Death through a Process Involving Induction of Endoplasmic Reticulum Stress Mol. Cell. Biol., August 1, 2007; 27(15): 5499 - 5513. [Abstract] [Full Text] [PDF]
|
|